Monoclonal antibodies generated by DNA immunization recognize CD2 from a broad range of primates

Immunology and Cell Biology

Volumn 87, Issue 5, 2009, Pages 413-418

  Brady, Jamie L ^a   Mannering, Stuart I ^b,d   Kireta, Svjetlana ^c   Coates, Patrick T ^c   Proietto, Anna I ^a   Cowan, Peter J ^b,d   D'Apice, Anthony J F ^b,d   Lew, Andrew M ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c QUEEN ELIZABETH HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

CD2; Depleting; DNA; Humanized mice; Monoclonal; Primate

Indexed keywords

CD2 ANTIBODY; MONOCLONAL ANTIBODY; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BABOON; CHO CELL; DNA IMMUNIZATION; HUMAN; MACACA; MARMOSET; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; STIMULATION; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD2; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CALLITHRIX; CELL PROLIFERATION; CHO CELLS; CRICETINAE; CRICETULUS; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LECTINS, C-TYPE; MACACA FASCICULARIS; MACACA NEMESTRINA; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; PAPIO HAMADRYAS; PHYLOGENY; PRIMATES; T-LYMPHOCYTES;

CERCOPITHECIDAE; MACACA FASCICULARIS; MUS; PAPIO; PLATYRRHINI; PRIMATES;

EID: 68149182703     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2009.4     Document Type: Article

References (45)

1. Davis SJ, van der Merwe PA. The structure and ligand interactions of CD2: implications for T-cell function. Immunol Today 1996; 17: 177-187.
2. Kamoun M, Martin PJ, Hansen JA, Brown MA, Siadak AW, Nowinski RC. Identification of a human T lymphocyte surface protein associated with the E-rosette receptor. JExp Med 1981; 153:207-212.
3. Moingeon P, Chang HC, Sayre PH, Clayton LK, Alcover A, Gardner P et al. The structural biology of CD2. Immunol Rev 1989; 111: 111-144.
4. Carmo AM, Castro MA, Arosa FA. CD2 and CD3 associate independently with CD5 and differentially regulate signaling through CD5 in Jurkat T cells. JImmunol 1999; 163: 4238-4245.
5. Verhagen AM, Schraven B, Wild M, Wallich R, Meuer SC. Differential interaction of the CD2 extracellular and intracellular domains with the tyrosine phosphatase CD45 and the zeta chain of the TCR/CD3/zeta complex. Eur J Immunol 1996; 26: 2841-2849.
6. Meuer SC, Hussey RE, Fabbi M, Fox D, Acuto O, Fitzgerald KA et al. An alternative pathway of T-cell activation: a functional role for the 50kD T11 sheep erythrocyte receptor protein. Cell 1984; 36: 897-906.
7. Yang SY, Chouaib S, Dupont B. A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants. JImmunol 1986; 137: 1097-1100.
8. Clark SJ, Law DA, Paterson DJ, Puklavec M, Williams AF. Activation of rat T lymphocytes byanti-CD2 monoclonal antibodies. JExp Med 1988; 167: 1861-1872.
9. Bockenstedt LK, Goldsmith MA, Dustin M, Olive D, Springer TA, Weiss A. The CD2 ligand LFA-3 activates Tcells but depends on the expression and function of the antigen receptor. JImmunol 1988; 141: 1904-1911.
10. Murray AG, Khodadoust MM, Pober JS, Bothwell AL. Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity1994; 1:57-63.
11. Boyle JS, Koniaras C, Lew AM. Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int Immunol 1997; 9: 1897-1906.
12. Kim M, Sun ZY, Byron O, Campbell G, Wagner G, Wang J et al. Molecular dissection of the CD2-CD58 counter-receptor interface identifies CD2 Tyr86 and CD58 Lys34 residues as the functional 'hot spot'. J Mol Biol 2001; 312: 711-720.
13. Wang JH, Smolyar A, Tan K, Liu JH, Kim M, Sun ZY et al. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors. Cell 1999; 97: 791-803.
14. Damschroder MM, Kozhich AA, Woods RM, Cheng L, Mullikin BA, Wilson SD et al. Analysis of human and primate CD2 molecules by protein sequence and epitope mapping with anti-human CD2 antibodies. Mol Immunol 2004; 41: 985-1000.
15. Bierer BE, Hahn WC. T cell adhesion, avidity regulation and signaling: a molecular analysis of CD2. Semin Immunol 1993; 5: 249-261.
16. De Rose R, Batten CJ, Smith MZ, Fernandez CS, Peut V, Thomson S et al. Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques. JVirol 2007; 81: 292-300.
17. Fazekas de St G, Webster RG. Disquisitions of original antigenic Sin. I. Evidence in man. JExp Med 1966; 124: 331-345.
18. Seed B, Aruffo A. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc Natl Acad Sci USA 1987; 84: 3365-3369.
19. Brok HP, Hornby RJ, Griffiths GD, Scott LA, Hart BA. An extensive monoclonal antibody panel for the phenotyping of leukocyte subsets in the common marmoset and the cotton-top tamarin. Cytometry 2001; 45: 294-303.
20. Pihusch R, Holler E, Muhlbayer D, Gohring P, StotzerO, Pihusch M et al. The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantation. Bone Marrow Transplant 2002; 30: 347-354.
21. Gaston RS, Deierhoi MH, Patterson T, Prasthofer E, Julian BA, Barber WH et al. OKT3 first-dose reaction: association with T cell subsets and cytokine release. Kidney Int 1991; 39: 141-148.
22. Winkler U, Jensen M, Manzke O, Schulz H, Diehl V, Engert A. Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC- C2B8). Blood 1999; 94: 2217-2224.
23. Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. NEnglJMed2006; 355: 1018-1028.
24. Bromberg JS, Chavin KD, Altevogt P, Kyewski BA, Guckel B, Naji A et al. Anti-CD2 monoclonal antibodiesaltercell-mediatedimmunityinvivo. Transplantation1991; 51: 219-225.
25. Chavin KD, Lau HT, Bromberg JS. Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies. Transplantation 1992; 54: 286-291.
26. Guckel B, Berek C, Lutz M, Altevogt P, Schirrmacher V, Kyewski BA. Anti-CD2 antibodies induce Tcell unresponsiveness in vivo. JExpMed1991; 174:957-967.
27. Stell D, Marshall H, Bradley JA, Bolton EM. CTLA4-Ig abrogates the anti-globulin response and prolongs cardiac allograft survival after anti-CD2 treatment. Transpl Immunol 2003; 12:1-7.
28. InomataT, WatanabeT, Haga M, Abo T, OkuraY, HanawaH et al. Anti-CD2 monoclonal antibodiespreventtheinduction ofexperimental autoimmunemyocarditis. JpnHeartJ 2000; 41: 507-517.
29. Van WauweJ, GoossensJ, DecockW, KungP, Goldstein G. Suppression ofhuman T-cell mitogenesisandE-rosetteformation bythemonoclonal antibodyOKT11A. Immunology 1981; 44: 865-871.
30. Giorgi JV, Burton RC, LVB, Delmonico FL, Goldstein G, Cosimi AB. Immunosuppressive effect and immunogenicity of OKT11A monoclonal antibody in monkey allograft recipients. Transplant Proc 1983; 15:639.
31. Thurlow PJ, Lovering E, d'Apice AJ, McKenzie IF. A monoclonal anti-pan-T-cell antibody. In vitro and in vivo studies. Transplantation 1983; 36: 293-298.
32. Latinne D, De La Parra B, Nizet Y, Cornet A, Giovino-Barry V, Monroy RL et al. An anti- CD2 mAb induces immunosuppression and hyporesponsiveness of CD2+ human Tcells in vitro. Int Immunol1996; 8: 1113-1119.
33. DehouxJP, TalpeS, Dewolf N, Otsuka M, OikeF, Jamar F et al. Effects on human and nonhuman primate immune response of a new rat anti-CD2 monoclonal antibody. Transplantation 2000; 69: 2622-2633.
34. Nizet Y, Chentoufi AA, de la Parra B, Lewalle P, Rouas R, Cornet A et al. The experimental (in vitro) and clinical (in vivo) immunosuppressive effects of a rat IgG2b anti-human CD2 mAb, LO-CD2a/BTI-322. Transplantation 2000; 69: 1420-1428.
35. Xu Y, Kolber-Simonds D, Hope JA, Bazin H, Latinne D, Monroy R et al. The anti-CD2 monoclonal antibody BTI-322 generates unresponsiveness by activation-associated T cell depletion. Clin ExpImmunol 2004; 138: 476-483.
36. Przepiorka D, Phillips GL, Ratanatharathorn V, Cottler-Fox M, Sehn LH, AntinJH et al. AphaseII studyofBTI-322, a monoclonal anti-CD2 antibody, for treatmentofsteroid- resistant acute graft-versus-host disease. Blood 1998; 92: 4066-4071.
37. Mourad M, Besse T, Malaise J, Baldi A, Latinne D, Bazin H et al. BTI-322 for acute rejection after renal transplantation. Transplant Proc 1997; 29: 2353.
38. Koenecke C, Shaffer J, Alexander SI, Preffer F, Dombkowski D, Saidman SL et al. NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507. ExpHematol 2003; 31: 911-923.
39. Lerut J, Van Thuyne V, Mathijs J, Lemaire J, Talpe S, Roggen F et al. Anti-CD2 monoclonal antibody and tacrolimus in adult liver transplantation. Transplantation 2005; 80: 1186-1193.
40. Shaffer J, Villard J, Means TK, Alexander S, Dombkowski D, DeyBR et al. Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludar- abine. ExpHematol 2007; 35: 1140-1152.
41. Shultz LD, Lyons BL, Burzenski LM, GottB, Chen X, Chaleff S et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R{gamma}null mice engrafted with mobilized human hemopoietic stem cells. JImmunol2005; 174: 6477-6489.
42. Boyle JS, Lew AM. An inexpensive alternative to glassmilk for DNA purification. Trends Genet 1995; 11:8.
43. Brady JL, Lew AM. Microplate digestion of minipreps from a single microcentrifuge tube. Biotechniques 1997; 22: 870, 73-4.
44. Boyle JS, Silva A, Brady JL, Lew AM. DNA immunization: induction of higher avidity antibodyand effectof route on Tcell cytotoxicity. Proc Natl AcadSci USA 1997; 94: 14626-14631.
45. ManneringSI, DromeyJA, Morris JS, Thearle DJ, Jensen KP, Harrison LC. An efficient method for cloning human autoantigen-specific T cells. J Immunol Methods 2005; 298:83-92